Selected advances in therapy of urologic cancer--luteinizing hormone releasing hormone (LHRH) and biologic response modifier (BUR). [electronic resource]
- Progress in clinical and biological research 1988
- 27-38 p. digital
Adenocarcinoma--pathology Buserelin--administration & dosage Clinical Trials as Topic Delayed-Action Preparations Goserelin Humans Injections, Subcutaneous Interleukin-2--therapeutic use Male Orchiectomy Prostatic Neoplasms--pathology Random Allocation Recombinant Proteins--therapeutic use